APA (7th ed.) Citation

Bérard, A., Strom, S., Zhao, J., Kori, S., & Albrecht, D. (2021). Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes. Scientific reports, 11(1), 19302-16. https://doi.org/10.1038/s41598-021-97092-y

Chicago Style (17th ed.) Citation

Bérard, Anick, Shannon Strom, Jin-Ping Zhao, Shashi Kori, and Detlef Albrecht. "Dihydroergotamine and Triptan Use to Treat Migraine During Pregnancy and the Risk of Adverse Pregnancy Outcomes." Scientific Reports 11, no. 1 (2021): 19302-16. https://doi.org/10.1038/s41598-021-97092-y.

MLA (9th ed.) Citation

Bérard, Anick, et al. "Dihydroergotamine and Triptan Use to Treat Migraine During Pregnancy and the Risk of Adverse Pregnancy Outcomes." Scientific Reports, vol. 11, no. 1, 2021, pp. 19302-16, https://doi.org/10.1038/s41598-021-97092-y.